Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Allogene Therapeutics Inc. logo

Allogene Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

2.35
 
USD
  
-0.19
  
(-0.07480315)
Optionable: Yes  Market Cap: 435676116.0  90-day average vol: 2289869.0

Previous close: 2.54  Open: 2.52  Bid: 2.34  Ask: 2.38
52 week range    
2.23   
   6.05
Last updated: Sunday 16th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ALLO Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles-452000.0603000.0
Basic EPS from continuing operations-1.83-2.08-1.89-2.32-2.09
Basic EPS total-1.83-2.08-1.89-2.32-2.09
Basic weighted shares outstanding29 M101 M120 M136 M143 M157 M
Depreciation-1000000.05 M7 M11 M14 M14 M
DepreciationAndAmortization-1000000.05 M7 M11 M14 M14 M
Diluted EPS total-7.31-1.83-2.08-1.89-2.32-2.09
Diluted normalized net income/share-1.89-2.32-2.09
Diluted weighted shares outstanding29 M101 M120 M136 M143 M157 M
GainOnSaleOfPPE200000.0100000.0100000.0100000.0
GeneralAndAdministrativeExpense41 M57 M65 M74 M79 M72 M
Gross operating profit38 M156000.095000.0
Income before tax-212 M-185 M-250 M-257 M-340 M-327 M
Income restructuring and M&A-1,038 M-526 M-248 M-439 M
Income taxes-117000.0-331000.0-19 M-692000.0-41 M-22 M
Interest income-21 M2 M5 M18 M
InterestExpenseNonOperating3 M
MiscOtherSpecialCharges6 M17 M9 M-3 M-9 M-18 M
Net income from total operations-212 M-185 M-250 M-257 M-340 M-327 M
NetIncomeCommonStockholders-212 M-185 M-250 M-257 M-340 M-327 M
NetIncomeContinuousOperations-212 M-185 M-250 M-257 M-340 M-327 M
NetNonOperatingInterestIncomeExpense-25 M2 M5 M18 M
Normalized income-774 M
Operating income-193 M-202 M-258 M-256 M-336 M-328 M
Operating income before depreciation (EBITDA)-203 M-180 M-243 M-247 M-326 M-313 M
OperatingExpense-193 M202 M258 M294 M336 M328 M
Other income net-6 M-17 M-9 M3 M9 M31 M
OtherGandA41 M57 M65 M74 M79 M72 M
OtherImpairmentOfCapitalAssets13 M
OtherOperatingExpenses-920000.0268000.01 M-4 M-5 M-4 M
RentAndLandingFees41 M6 M
Research & development expense152 M145 M193 M220 M256 M243 M
ResearchExpense152 M145 M193 M220 M256 M243 M
RestructringAndMnAIncome-1,038 M-526 M-248 M-439 M
Revenue per share-452000.0603000.0
SalariesAndWages-19 M60 M60 M
Selling Gen & administrative expense41 M57 M65 M74 M79 M72 M
Special income/charges1,038 M526 M248 M439 M
Total Income available for interest expense (EBIT)-208 M-185 M-250 M-257 M-340 M-327 M
Total common shares outstanding121 M125 M141 M143 M144 M169 M
Total net income-212 M-185 M-250 M-257 M-340 M-327 M
Total ordinary shares171 M171 M171 M171 M171 M171 M
Total revenues38 M156000.095000.0
TotalExpenses-193 M202 M258 M294 M336 M328 M
TotalRevenue38 M156000.095000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University